Investigator Oversight Deficiencies in Clinical Trial Audit Reports
Investigator Oversight Deficiencies in Clinical Trial Audit Reports Investigator Oversight Deficiencies in Clinical Trial Audit Reports Introduction: The Critical Role of Investigator Oversight Principal Investigators (PIs) hold ultimate responsibility for the conduct of clinical trials at their sites. Regulatory agencies such as the FDA, EMA, and MHRA consistently identify inadequate investigator oversight as a major…
Read More “Investigator Oversight Deficiencies in Clinical Trial Audit Reports” »